Aspira Women's Health Inc. AWHL

0.26 0.00 0.00% as of 25 Sep
Market cap
$2.4M
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
21.74 32.86 6.89 15.46 145.39 28.90 4.56 4.22 1.09 2.33
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(20.78) (47.65) (9.15) (24.44) (142.18) (25.73) (5.27) (11.19) (9.83) (10.85)
P/B ratio
15.27 30.10 2.94 8.03 69.57 6.52 5.34 0.00 0.00 0.00
Price to Tangible BV
15.27 30.10 2.94 8.03 69.57 6.52 5.34 0.00 0.00 0.00
EV/Sales
20.46 31.62 4.31 13.24 142.83 23.98 3.36 4.18 1.13 2.33
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
(3.87) (12.14) (1.40) (4.63) (45.09) (5.96) (0.88) (2.41) (0.86) (3.06)
EV/FCF
(3.55) (12.05) (1.39) (4.59) (43.63) (5.92) (0.88) (2.40) (0.85) (3.05)
Quick Ratio
2.15 2.20 3.42 3.17 2.92 4.87 2.63 0.79 0.50 0.85
Current Ratio
2.39 2.42 3.64 3.37 3.10 5.10 2.95 1.03 0.77 1.17
Net Debt/EBITDA
0.24 0.40 0.74 0.68 0.67 1.04 0.32 0.02 (0.02) 0.00
Debt/Assets
23.06% 22.22% 12.98% 11.53% 24.14% 9.00% 20.04% 36.19% 38.63% 32.44%
Debt/Equity
0.49 0.49 0.21 0.18 0.49 0.12 0.50 (0.96) (0.83) (0.26)
Asset Turnover
0.18 0.40 0.32 0.36 0.28 0.22 0.28 0.77 1.56 1.68
Operating CF/Net income
0.93 0.71 0.82 0.85 0.82 0.87 1.04 0.95 0.93 0.55
Capex/Depreciation
(1.74) (0.08) (0.17) (0.40) (1.85) (0.61) (0.88) (0.12) (0.40) (3.58)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(140.49%) (319.12%) (215.38%) (191.78%) (194.02%) (158.74%) (160.88%) (723.45%) 531.42% 269.20%
ROA
(103.30%) (147.45%) (120.30%) (120.76%) (107.11%) (104.35%) (102.25%) (141.23%) (222.82%) (233.49%)
ROIC
(2,532.86%) 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(274.24%) (234.55%) (134.86%) (155.72%) (135.79%) (97.04%) (268.03%) (5,119.63%) 1,076.81% (1,981.40%)
Average Days of Receivables
37.99 23.97 93.97 74.32 67.88 55.03 55.53 58.18 39.35 47.80
Research and Development Expense of Revenue
82.21% 26.82% 18.02% 22.43% 45.24% 78.01% 72.30% 44.08% 35.57% 31.23%
Selling, General and Administrative Expense of Revenue
481.68% 314.35% 350.28% 340.57% 367.94% 445.43% 361.00% 219.35% 201.38% 118.82%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06
Share Based Compensation of Revenue
44.63% 46.11% 36.06% 26.29% 33.28% 51.95% 29.50% 18.83% 16.27% 5.76%
Graham Net Nets
0.03 0.02 0.31 0.12 0.01 0.15 0.16 (0.09) (0.39) (0.39)
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.27 2.00 1.30
Earnings Yield
(25.44%) (11.11%) (56.64%) (22.21%) (2.67%) (15.81%) (80.11%) (44.29%) (138.03%) (58.65%)
Free Cash Flow Yield
(26.50%) (7.99%) (45.07%) (18.66%) (2.25%) (14.01%) (83.93%) (41.24%) (121.07%) (32.80%)
Revenue per Share
0.76 0.82 0.65 0.79 0.69 0.92 1.05 0.99 0.65 0.27
Operating CF per Share
(4.01) (2.14) (2.00) (2.24) (2.19) (3.69) (4.00) (1.72) (0.86) (0.21)
Capex per Share
(0.36) (0.02) (0.02) (0.02) (0.07) (0.02) (0.03) 0.00 0.00 (0.01)
Free Cash Flow per Share
(4.37) (2.16) (2.03) (2.27) (2.27) (3.72) (4.03) (1.72) (0.86) (0.22)
Cash per Share
1.51 1.46 2.00 2.03 2.48 5.01 1.71 0.28 0.13 0.05
Shareholders Equity per Share
1.08 0.90 1.53 1.51 1.45 4.07 0.90 (0.26) (0.18) (0.20)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
1.08 0.90 1.53 1.51 1.45 4.07 0.90 (0.26) (0.18) (0.20)
Free Cash Flow
(15.22) (8.19) (9.48) (13.10) (15.22) (27.58) (31.30) (15.92) (12.15) (7.43)
Working Capital
3.55 3.70 7.82 9.43 12.60 32.17 10.78 0.16 (1.28) 0.60
Capital Expenditures
(1.26) (0.06) (0.11) (0.13) (0.49) (0.18) (0.23) (0.02) (0.04) (0.40)
Net Current Asset Value
1.85 2.22 6.53 8.32 8.72 29.10 5.92 (3.35) (3.87) (8.32)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.48 0.02 0.04 0.03 0.11 0.03 0.03 0.00 0.00 0.04
Net Profit Margin
(566.54%) (366.52%) (372.45%) (335.76%) (384.97%) (464.80%) (365.16%) (182.32%) (142.61%) (138.67%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.38 0.67 1.11 0.94 0.45 0.65 0.72 1.21 1.33 2.38
Cash ROIC
(146.26%) (87.73%) (55.44%) (60.44%) (49.28%) (39.21%) (132.27%) (642.87%) (918.01%) 207.69%
Accounts Receivable Turnover
14.60 13.00 6.16 5.31 5.20 7.20 7.20 6.77 7.50 8.39
Accounts Payable Turnover
2.89 3.58 3.71 3.70 3.49 2.88 3.24 3.63 2.16 1.94
Inventory Turnover
29.98 29.89 32.39 57.15 124.18 36.76 15.76 14.34 13.39 11.34
Average Days of Payables
119.19 93.32 110.36 93.35 117.89 146.10 83.29 118.26 214.19 136.78
Days of Inventory on Hand
12.58 12.78 10.69 2.73 3.21 16.94 29.87 21.29 32.13 28.31
Average Receivables
0.18 0.24 0.50 0.86 0.89 0.95 1.14 1.35 1.22 1.10
Average Payables
0.93 0.81 0.85 0.90 0.98 1.30 1.19 1.07 1.72 1.71
Average Inventory
0.09 0.10 0.10 0.06 0.03 0.10 0.25 0.27 0.28 0.29
Average Assets
14.49 7.76 9.45 12.62 16.72 30.34 29.23 11.82 5.88 5.47
Average Common Equity
10.65 3.58 5.28 7.95 9.23 19.95 18.58 2.31 (2.46) (4.75)

Fold the line items

Columns are period end dates